Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads N Holten-Andersen; Ib Jarle Christensen; Nils Brünner; Hans Jørgen Nielsen

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Mads N Holten-Andersen (Opfinder), Ib Jarle Christensen (Opfinder), Nils Brünner (Opfinder), Hans Jørgen Nielsen (Opfinder)

Institut for Klinisk Medicin

Abstract

The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

Originalsprog	Engelsk
Patentnummer	US 2003/0082652 A1
Journaliseringsdato	08/04/2002
Status	Udgivet - 2002

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

http://www.google.com/patents?id=jLyJAAAAEBAJ&dq=Hvidovre+hospital

Citationsformater

@misc{3628cb44fbdd48a5986ac30a18b165ff,

title = "Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker",

abstract = "The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.",

author = "Holten-Andersen, {Mads N} and Christensen, {Ib Jarle} and Nils Br{\"u}nner and Nielsen, {Hans J{\o}rgen}",

note = "U.S. Classification 435007230 International Classification G01N033/574; US 2003/0082652 A1",

year = "2002",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

AU - Holten-Andersen, Mads N

AU - Christensen, Ib Jarle

AU - Brünner, Nils

AU - Nielsen, Hans Jørgen

N1 - U.S. Classification 435007230 International Classification G01N033/574

PY - 2002

Y1 - 2002

N2 - The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

AB - The present invention describes a method for determining whether an individual is suffering from cancer by determining a parameter representing the TIMP-1 concentration in body fluid samples from the individual.

M3 - Patent

M1 - US 2003/0082652 A1

Y2 - 2002/04/08

ER -

Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater